Toward a global classification of mast cell activation diseases

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 5, 2011, Pages 1311-

  Molderings, Gerhard J ^a   Homann, Jürgen ^b   Raithel, Martin ^c   Frieling, Thomas ^d  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Evangelische Kliniken Waldkrankenhaus   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d HELIOS KLINIKUM KREFELD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; TYROSINE KINASE KIT; UNCLASSIFIED DRUG;

BONE MARROW BIOPSY; CLINICAL PRACTICE; DISEASE CLASSIFICATION; GENE MUTATION; HUMAN; IMMUNOPATHOLOGY; LETTER; MAST CELL ACTIVATION SYNDROME; MEDIATOR RELEASE; NOMENCLATURE; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; WORLD HEALTH ORGANIZATION;

HUMANS; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; SYNDROME; WORLD HEALTH ORGANIZATION;

EID: 79955615954     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.12.1113     Document Type: Letter

References (7)

1. C. Akin, P. Valent, and D.D. Metcalfe Mast cell activation syndrome: proposed diagnostic criteria J Allergy Clin Immunol 126 2010 1099 1104
2. J. Homann, U.W. Kolck, A. Ehnes, T. Frieling, M. Raithel, and G.J. Molderings Systemic mastocytosis - definition of an internal disease Med Klin (Munich) 105 2010 544 553
3. I. Alvarez-Twose, D. González de Olano, L. Sánchez- Muñoz, A. Matito, M.I. Esteban-López, and A. Vega Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms J Allergy Clin Immunol 125 2010 1269 1278
4. C. Teodosio, A.C. García-Montero, M. Jara-Acevedo, L. Sánchez-Muñoz, I. Alvarez-Twose, and R. Núñez Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes J Allergy Clin Immunol 125 2010 719 726
5. Y. Yang, S. Létard, and L. Borge Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations Blood 116 2010 1114 1123
6. G.J. Molderings, K. Meis, U.W. Kolck, J. Homann, and T. Frieling Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects Immunogenetics 62 2010 721 727
7. T.C. Theoharides, D. Kempuraj, M. Tagen, P. Conti, and D. Kalogeromitros Differential release of mast cell mediators and the pathogenesis of inflammation Immunol Rev 217 2007 65 78 (Pubitemid 46718152)